GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.

<h4>Background</h4>The last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication. Last studies suggested benef...

Full description

Saved in:
Bibliographic Details
Main Authors: Guillaume Grenet, Shams Ribault, Giao Bao Nguyen, Faustine Glais, Augustin Metge, Thomas Linet, Behrouz Kassai-Koupai, Catherine Cornu, Théodora Bejan-Angoulvant, Sylvie Erpeldinger, Rémy Boussageon, Aurore Gouraud, Fabrice Bonnet, Michel Cucherat, Philippe Moulin, François Gueyffier
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0217701/1/pone.0217701.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210222%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210222T184324Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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
Tags: Add Tag
No Tags, Be the first to tag this record!